Literature DB >> 20691235

2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb/c mice.

T Sengupta1, K P Mohanakumar.   

Abstract

Behavioral and neurochemical effects of chronic administration of high doses of 2-phenylethylamine (PEA; 25-75 mg/kg, i.p. for up to 7 days) have been investigated in Balb/c mice. Depression and anxiety, as demonstrated respectively by increased floating time in forced swim test, and reduction in number of entries and the time spent in the open arms in an elevated plus maze were observed in these animals. General motor disabilities in terms of akinesia, catalepsy and decreased swimming ability were also observed in these animals. Acute and sub-acute administration of PEA caused significant, dose-dependent depletion of striatal dopamine, and its metabolites levels. PEA caused dose-dependent generation of hydroxyl radicals in vitro in Fenton's reaction in test tubes, in isolated mitochondrial fraction, and in vivo in the striatum of mice. A significant inhibition of NADH-ubiquinone oxidoreductase (complex-I; EC: 1.6.5.3) activity suggests the inhibition in oxidative phosphorylation in the mitochondria resulting in hydroxyl radical generation. Nissl staining and TH immnunohistochemistry in brain sections failed to show any morphological aberrations in dopaminergic neurons or nerve terminals. Long-term over-consumption of PEA containing food items could be a neurological risk factor having significant pathological relevance to disease conditions such as depression or motor dysfunction. However, per-oral administration of higher doses of PEA (75-125 mg/kg; 7 days) failed to cause such overt neurochemical effects in rats, which suggested safe consumption of food items rich in this trace amine by normal population.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691235     DOI: 10.1016/j.neuint.2010.07.013

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.

Authors:  T Sengupta; J Vinayagam; N Nagashayana; B Gowda; P Jaisankar; K P Mohanakumar
Journal:  Neurochem Res       Date:  2010-10-23       Impact factor: 3.996

Review 3.  Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease.

Authors:  Anupom Borah; Rajib Paul; Muhammed Khairujjaman Mazumder; Nivedita Bhattacharjee
Journal:  Neurosci Bull       Date:  2013-04-10       Impact factor: 5.203

4.  Phenethylamine in chlorella alleviates high-fat diet-induced mouse liver damage by regulating generation of methylglyoxal.

Authors:  Yifeng Zheng; Agustin Martin-Morales; Jing Wang; Masaki Fujishima; Eri Okumura; Kenji Sato
Journal:  NPJ Sci Food       Date:  2021-07-23

5.  Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease.

Authors:  Nivedita Bhattacharjee; Rajib Paul; Anirudha Giri; Anupom Borah
Journal:  Biochem Biophys Rep       Date:  2016-02-26

6.  The cytotoxicity of the α1-adrenoceptor antagonist prazosin is linked to an endocytotic mechanism equivalent to transport-P.

Authors:  Robert Fuchs; Anika Stracke; Nadine Ebner; Christian Wolfgang Zeller; Anna Maria Raninger; Matthias Schittmayer; Tatjana Kueznik; Markus Absenger-Novak; Ruth Birner-Gruenberger
Journal:  Toxicology       Date:  2015-10-09       Impact factor: 4.221

Review 7.  Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson's Disease.

Authors:  Alejandra Guillermina Miranda-Díaz; Andrés García-Sánchez; Ernesto Germán Cardona-Muñoz
Journal:  Oxid Med Cell Longev       Date:  2020-08-03       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.